TY - JOUR A1 - Hardenbol, Paul A1 - Yu, Fuli A1 - Belmont, John A1 - MacKenzie, Jennifer A1 - Bruckner, Carsten A1 - Brundage, Tiffany A1 - Boudreau, Andrew A1 - Chow, Steve A1 - Eberle, Jim A1 - Erbilgin, Ayca A1 - Falkowski, Mat A1 - Fitzgerald, Ron A1 - Ghose, Sy A1 - Iartchouk, Oleg A1 - Jain, Maneesh A1 - Karlin-Neumann, George A1 - Lu, Xiuhua A1 - Miao, Xin A1 - Moore, Bridget A1 - Moorhead, Martin A1 - Namsaraev, Eugeni A1 - Pasternak, Shiran A1 - Prakash, Eunice A1 - Tran, Karen A1 - Wang, Zhiyong A1 - Jones, Hywel B. A1 - Davis, Ronald W. A1 - Willis, Thomas D. A1 - Gibbs, Richard A. T1 - Highly multiplexed molecular inversion probe genotyping: Over 10,000 targeted SNPs genotyped in a single tube assay Y1 - 2005/02/01 JF - Genome Research JO - Genome Research SP - 269 EP - 275 DO - 10.1101/gr.3185605 VL - 15 IS - 2 UR - http://genome.cshlp.org/content/15/2/269.abstract N2 - Large-scale genetic studies are highly dependent on efficient and scalable multiplex SNP assays. In this study, we report the development of Molecular Inversion Probe technology with four-color, single array detection, applied to large-scale genotyping of up to 12,000 SNPs per reaction. While generating 38,429 SNP assays using this technology in a population of 30 trios from the Centre d'Etude Polymorphisme Humain family panel as part of the International HapMap project, we established SNP conversion rates of ∼90% with concordance rates >99.6% and completeness levels >98% for assays multiplexed up to 12,000plex levels. Furthermore, these individual metrics can be “traded off” and, by sacrificing a small fraction of the conversion rate, the accuracy can be increased to very high levels. No loss of performance is seen when scaling from 6,000plex to 12,000plex assays, strongly validating the ability of the technology to suppress cross-reactivity at high multiplex levels. The results of this study demonstrate the suitability of this technology for comprehensive association studies that use targeted SNPs in indirect linkage disequilibrium studies or that directly screen for causative mutations. ER -